Protons, the brainstem, and toxicity: Ingredients for an emerging dialectic

References

• Heikens J, Michiels EM, Behrendt H, Endert E, Bakker PJ, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer 1998; 34:1592–7.
   PubMed Web of Science ®Google Scholar
• Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5:399–408.
   PubMed Web of Science ®Google Scholar
• Paulino AC, Lobo M, Teh BS, Okcu MF, South M, Butler EB, et al. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys 2010; 78:1445–50.
   PubMed Web of Science ®Google Scholar
• Armstrong GT. Long-term survivors of childhood central nervous system malignancies: The experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 2010;14:298–303.
   PubMed Web of Science ®Google Scholar
• Kuhlthau KA, Pulsifer MB, Yeap BY, Rivera Morales D, Delahaye J, Hill KS, et al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 2012;30:2079–86.
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572–82.
   PubMed Web of Science ®Google Scholar
• Yock TI, Tarbell NJ. Technology insight: Proton beam radiotherapy for treatment in pediatric brain tumors. Nature Clin Pract Oncol 2004;1:97–103.
   PubMedGoogle Scholar
• Indelicato DJ, Flampouri S, Rotondo RL, Bradley JA, Morris CG, Aldana PR, et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 2014;53:1298–304.
   Google Scholar
• Merchant TE, Chitti RM, Li C, Xiong X, Sanford RA, Khan RB. Factors associated with neurological recovery of brainstem function following postoperative conformal radiation therapy for infratentorial ependymoma. Int J Radiat Oncol Biol Phys 2010;76:496–503.
   PubMed Web of Science ®Google Scholar
• Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, et al. Necrosis after craniospinal irradiation: Results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 2012;83:e655–60.
   PubMed Web of Science ®Google Scholar
• Spreafico F, Gandola L, Marchiano A, Simonetti F, Poggi G, Adduci A, et al. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors. Int J Radiat Oncol Biol Phys 2008;70: 1011–9.
   PubMed Web of Science ®Google Scholar
• Chao ST, Ahluwalia MS, Barnett GH, Stevens GH, Murphy ES, Stockham AL, et al. Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys 2013;87:449–57.
   PubMed Web of Science ®Google Scholar
• Debus J, Hug EB, Liebsch NJ, O’Farrel D, Finkelstein D, Efird J, et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 1997; 39:967–75.
   PubMed Web of Science ®Google Scholar
• Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 2010; 76(Suppl):S36–41.
   PubMedGoogle Scholar
• Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006;65:499–508.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol 2009;10:258–66.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21: 109–22.
   PubMed Web of Science ®Google Scholar
• Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: A report from the Children's Oncology Group. Neurooncology 2011;13:410–6.
   PubMed Web of Science ®Google Scholar
• Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: A Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 1993;27:197–206.
   PubMed Web of Science ®Google Scholar
• Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 1994;74:1827–34.
   Google Scholar
• Sangra M, Thorp N, May P, Pizer B, Mallucci C. Management strategies for recurrent ependymoma in the paediatric population. Childs Nerv Syst 2009;25:1283–91.
   PubMed Web of Science ®Google Scholar
• Macdonald SM, Sethi R, Lavally B, Yeap BY, Marcus KJ, Caruso P, et al. Proton radiotherapy for pediatric central nervous system ependymoma: Clinical outcomes for 70 patients. Neurooncology 2013;15:1552–9.
   PubMed Web of Science ®Google Scholar
• Mohan R, Mahajan A, Minsky BD. New strategies in radiation therapy: Exploiting the full potential of protons. Clin Cancer Res 2013;19:6338–43.
   PubMed Web of Science ®Google Scholar
• Paganetti H, van Luijk P. Biological considerations when comparing proton therapy with photon therapy. Sem Radiat Oncol 2013;23:77–87.
   PubMed Web of Science ®Google Scholar
• Buchsbaum JC, McDonald MW, Johnstone PA, Hoene T, Mendonca M, Cheng CW, et al. Range modulation in proton therapy planning: A simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams. Radiat Oncol 2014;9:2.
   PubMed Web of Science ®Google Scholar